GenMont Biotech (Taiwan) Price on September 3, 2024
| 3164 Stock | TWD 20.05 0.10 0.50% |
If you're considering investing in GenMont Stock, it is important to understand the factors that can impact its price. As of today, the current price of GenMont Biotech stands at 20.05, as last reported on the 23rd of November, with the highest price reaching 20.35 and the lowest price hitting 20.00 during the day. GenMont Biotech holds Efficiency (Sharpe) Ratio of -0.3, which attests that the entity had a -0.3% return per unit of risk over the last 3 months. GenMont Biotech exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out GenMont Biotech's Risk Adjusted Performance of (0.16), standard deviation of 0.9553, and Market Risk Adjusted Performance of 6.32 to validate the risk estimate we provide.
GenMont Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
GenMont |
Sharpe Ratio = -0.3003
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 3164 |
Estimated Market Risk
| 0.87 actual daily | 7 93% of assets are more volatile |
Expected Return
| -0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.3 actual daily | 0 Most of other assets perform better |
Based on monthly moving average GenMont Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GenMont Biotech by adding GenMont Biotech to a well-diversified portfolio.
GenMont Biotech Valuation on September 3, 2024
It is possible to determine the worth of GenMont Biotech on a given historical date. On September 3, 2024 GenMont was worth 23.45 at the beginning of the trading date compared to the closed value of 23.3. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of GenMont Biotech stock. Still, in general, we apply an absolute valuation method to find GenMont Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of GenMont Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against GenMont Biotech's related companies.
| Open | High | Low | Close | Volume | |
| 23.75 | 23.75 | 23.40 | 23.45 | 44,828 | |
09/03/2024 | 23.45 | 23.45 | 23.30 | 23.30 | 24,203 |
| 22.45 | 23.65 | 22.45 | 22.85 | 117,384 |
| Backtest GenMont Biotech | | | GenMont Biotech History | | | GenMont Biotech Valuation | Previous | Next |
GenMont Biotech Trading Date Momentum on September 3, 2024
| On September 04 2024 GenMont Biotech was traded for 22.85 at the closing time. The highest price during the trading period was 23.65 and the lowest recorded bid was listed for 22.45 . The volume for the day was 117.4 K. This history from September 4, 2024 contributed to the next trading day price decline. The daily price change to the next closing price was 1.93% . The overall trading delta to the current price is 0.64% . |
GenMont Biotech Fundamentals Correlations and Trends
By evaluating GenMont Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among GenMont Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. GenMont financial account trend analysis is a perfect complement when working with valuation or volatility modules.About GenMont Biotech Stock history
GenMont Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GenMont is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in GenMont Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing GenMont Biotech stock prices may prove useful in developing a viable investing in GenMont Biotech
GenMont Biotech Incorporation engages in the research, development, and production of functional probiotics in Taiwan. The company was founded in 2000 and is based in Tainan, Taiwan. GENMONT BIOTECH operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.
GenMont Biotech Stock Technical Analysis
GenMont Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
GenMont Biotech Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
GenMont Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on Taiwan Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
GenMont Biotech November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how GenMont Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GenMont Biotech shares will generate the highest return on investment. By undertsting and applying GenMont Biotech stock market strength indicators, traders can identify GenMont Biotech entry and exit signals to maximize returns
GenMont Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for GenMont Biotech's price direction in advance. Along with the technical and fundamental analysis of GenMont Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of GenMont to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.16) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.36) | |||
| Treynor Ratio | 6.31 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for GenMont Stock Analysis
When running GenMont Biotech's price analysis, check to measure GenMont Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GenMont Biotech is operating at the current time. Most of GenMont Biotech's value examination focuses on studying past and present price action to predict the probability of GenMont Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GenMont Biotech's price. Additionally, you may evaluate how the addition of GenMont Biotech to your portfolios can decrease your overall portfolio volatility.